首页 | 本学科首页   官方微博 | 高级检索  
     


Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib,with Malassezia-specific immunoglobulin E levels mirroring clinical response
Affiliation:1. Department of Dermatology, Liverpool Hospital, Sydney, Australia;2. Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, Australia;3. University of New South Wales, Sydney, Australia;1. Department of Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania;2. Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, Florida;3. Department of Surgery, Duke University, Durham, North Carolina;4. Department of Surgery, Emory University, Atlanta, Georgia;5. Division of Surgical Oncology, Department of Surgery, University of Virginia, Charlottesville, Virginia;6. Division of Head and Neck Surgical Oncology, Department of Otolaryngology - Head and Neck Surgery, University of Virginia, Charlottesville, Virginia;7. Cedars-Sinai Medical Center, The Angeles Clinic and Research Institute, Los Angeles, California;8. Division of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania;9. Department of Oncological Sciences at the University of South Florida, Morsani College of Medicine, Tampa, Florida;1. Department of Dermatology, Concord Hospital, The University of Sydney Medical School, Sydney, Australia;2. Department of Dermatology, Harvard Medical School, Boston, Massachusetts;3. Beth Israel Deaconess Medical Center, Boston, Massachusetts;4. Department of Medicine, University of Tasmania Medical School, Launceston, Tasmania, Australia;5. Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;1. American Academy of Dermatology Association, Washington, District of Columbia;2. Department of Dermatology, School of Medicine, Wayne State University, Dearborn, Michigan;3. American Academy of Dermatology Association, Rosemont, Illinois;4. Department of Dermatology, The School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin;5. Division of Dermatology, Washington University School of Medicine, St Louis, Missouri;6. Roseburg Dermatology, Roseburg, Oregon;1. Division of Dermatology, Department of Medicine, J.H. Stroger Hospital of Cook County, Chicago, Illinois;2. Department of Dermatology, Rush Medical College, Chicago, Illinois;3. Department of Dermatology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts;1. Uniformed Services University, Bethesda, Maryland;2. Chief of Dermatology, 96th Medical Group, Eglin Air Force Base, Florida;3. Headquarters Air Education and Training Command, Joint Base San Antonio-Randolph, Texas;4. United States Air Force School of Aerospace Medicine, Wright-Patterson Air Force Base, Ohio;5. 492nd Special Operations Support Squadron, Duke Field Air Force Base, Florida;6. Strike Fighter Squadron 101, Eglin Air Force Base, Florida;7. 24th Special Operations Wing, Hurlburt Field, Florida;8. 96th Medical Group, Eglin Air Force Base, Florida
Abstract:
Keywords:atopic dermatitis  dupilumab  facial erythema  itraconazole  Janus kinase
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号